Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Atherosclerosis
    December 2025
  1. NOVO G, Arcari L, Madaudo C, Greco A, et al
    Blood Cell Subtype patterns in Takotsubo Syndrome and acute coronary syndrome: analysis from the GEIST registry.
    Atherosclerosis. 2025;411:120571.
    >> Share

  2. JAE SY, Cho DH, Kunutsor SK, Choi J, et al
    Sex differences in mortality associated with physical activity before and after acute coronary syndrome.
    Atherosclerosis. 2025;411:120559.
    >> Share

  3. YANG D, Wang G
    Beyond quantity: The nonlinear association between HDL cholesterol and coronary atherosclerosis.
    Atherosclerosis. 2025;411:120561.
    >> Share

    November 2025
  4. SCILLETTA S, Welsh P, Beazer JD, Di Pino A, et al
    Ethnic differences in HDL quantity, quality, and potential associations with coronary heart disease risk.
    Atherosclerosis. 2025;411:120565.
    >> Share

  5. TONG E, Chen Y, Chen C, Zhang F, et al
    Global, regional and national burden of ischemic heart disease attributable to ambient fine particulate matter pollution from 1990 to 2021, with predictions to 2072: An analysis of the global burden of disease study 2021.
    Atherosclerosis. 2025;410:120498.
    >> Share

  6. MESEGUER-HERNANDEZ A, Buendia-Santiago F, Andreu-Cayuelas JM, Merino-Romero J, et al
    Atherogenic responsibility of lipoprotein (a) and other apolipoprotein B-containing lipoproteins in acute coronary syndrome.
    Atherosclerosis. 2025;410:120544.
    >> Share

  7. KALHOR P, Mahmoudi Hamidabad N, Hellou E, Nogami K, et al
    Association of monocyte-to-lymphocyte ratio with coronary endothelial dysfunction and cardiovascular events in patients with angina and nonobstructive coronary artery disease.
    Atherosclerosis. 2025;410:120539.
    >> Share

  8. KUKU KO, Garcia-Garcia HM, Mintz GS, Shah P, et al
    Coronary lipid burden indices predict non-culprit major adverse cardiac events independently of novel LDL estimates: Insights from the LRP study.
    Atherosclerosis. 2025;410:120525.
    >> Share

  9. LAUKKANEN JA, Pohjonen T, Kurl S, Kunutsor SK, et al
    Associations of high-density lipoprotein cholesterol levels with the presence and severity of coronary atherosclerosis.
    Atherosclerosis. 2025;410:118629.
    >> Share

  10. LEGGET ME, Earle NJ, Poppe KK, Bradbury KE, et al
    Lipoprotein(a) concentrations and secondary outcomes following first-time acute coronary syndrome: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS).
    Atherosclerosis. 2025;410:120516.
    >> Share

    October 2025
  11. GIZARD F, Mohamedi N
    Influence of a mitochondria-associated membranes (MAMs) linker protein on coronary calcification: Commentary on "GRP75 inhibition attenuates arterial calcification" by Heyn J et al. Atherosclerosis 2025.
    Atherosclerosis. 2025;409:120497.
    >> Share

  12. XU Q, Jin C, Qin Z, Zhao P, et al
    Ambient temperature and coronary plaque rupture risk in STEMI: Insights from OCT analysis.
    Atherosclerosis. 2025;409:120510.
    >> Share

  13. ARTHI SRI AS, Veeraraghavan VP, Patil S, Raj AT, et al
    Identification of salivary inflammatory non coding RNA biomarkers for coronary artery disease through epicardial adipose tissue gene network analysis.
    Atherosclerosis. 2025;409:120486.
    >> Share

  14. ARNOLD N, Gossling A, Weimann J, Bay B, et al
    Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk.
    Atherosclerosis. 2025;409:120475.
    >> Share

  15. SILBERNAGEL G, Higbie H, Meininger T, Lemen D, et al
    Associations of ANGPTL proteins and complexes with progression of coronary artery calcification and coronary events.
    Atherosclerosis. 2025;409:120485.
    >> Share

  16. AHN WJ, Rha SW, Choi BG, Choi SY, et al
    Long-term clinical outcomes according to first responsive dose of acetylcholine in patients with coronary artery spasm.
    Atherosclerosis. 2025;409:120473.
    >> Share

  17. ATALLAH M, Harb T, Nasrallah N, Jones SR, et al
    Oxidized phospholipid dynamics in the early post-infarction period: Effects of PCSK9 inhibition with evolocumab.
    Atherosclerosis. 2025;409:120469.
    >> Share

  18. MANUBOLU VS, Kinninger A, Lakshmanan S, Dahal S, et al
    Ethnic differences in coronary plaque burden and characteristics: A matched CCTA cohort study of South Asians and non-Hispanic Whites.
    Atherosclerosis. 2025;409:120455.
    >> Share

  19. OLIVA A, Shneyderman M, Gitto M, Sartori S, et al
    Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2025;410:120523.
    >> Share

    September 2025
  20. RAMASAMY A, Sivananthan A, Mohammed A, Kumaran S M T, et al
    Implications of imaging modalities on coronary vessel reconstruction and computation of the local hemodynamic forces.
    Atherosclerosis. 2025;408:120423.
    >> Share

  21. CEDERSTROM S, Wang Y, Lundman P, Alfredsson J, et al
    Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals - an observational cross-sectional study.
    Atherosclerosis. 2025;408:120457.
    >> Share

    August 2025
  22. TSCHARRE M, Mutschlechner D, Huber K, Gremmel T, et al
    Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
    Atherosclerosis. 2025;409:120478.
    >> Share

  23. CANDREVA A, Morbiducci U, Erriquez A, Rizzini ML, et al
    Enhanced coronary physiology assessment with endothelial shear stress predicts residual cardiovascular risk in older patients with myocardial infarction.
    Atherosclerosis. 2025;409:120476.
    >> Share

  24. KITAHARA S, Kataoka Y, Nicholls SJ, Funabashi S, et al
    Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trial.
    Atherosclerosis. 2025;409:120470.
    >> Share

  25. MUENDLEIN A, Leiherer A, Brandtner EM, Geiger K, et al
    Serum leucine-rich alpha-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patients.
    Atherosclerosis. 2025;407:120413.
    >> Share

  26. ALDUJELI A, Tsai TY, Haq A, Puipaite K, et al
    Impact of severe COVID-19 infection on coronary microvascular dysfunction in ANOCA patients: A cross-sectional study.
    Atherosclerosis. 2025;407:120389.
    >> Share

    July 2025
  27. TOFT-NIELSEN F, Emanuelsson F, Nordestgaard BG, Benn M, et al
    Clinical familial hypercholesterolemia, heart healthy dietary adherence, and cardiovascular risk.
    Atherosclerosis. 2025 Jul 24:120463. doi: 10.1016/j.atherosclerosis.2025.120463.
    >> Share

  28. GALIMBERTI F, Olmastroni E, Casula M, Xie S, et al
    Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular risk.
    Atherosclerosis. 2025;408:120451.
    >> Share

  29. RIVERO-SANTANA B, Saldana-Garcia J, Jurado-Roman A, Cantolla-Pablo P, et al
    Early anti-inflammatory therapy in acute myocardial infarction: A network meta-analysis of timing-dependent effects in 23 randomized trials and 28,220 patients.
    Atherosclerosis. 2025;408:120443.
    >> Share

  30. WHITE JB, Lin A, Montarello NJ, Bursill CA, et al
    Changes to the serum lipidome and their relation to coronary plaque in the first six months after acute myocardial infarction.
    Atherosclerosis. 2025;408:120421.
    >> Share

  31. TADA H, Furukawa A, Kojima N, Usui S, et al
    Protein-truncating variants of the cholesteryl ester transfer protein gene and risk for coronary artery disease among patients with heterozygous familial hypercholesterolemia.
    Atherosclerosis. 2025;408:120417.
    >> Share

    June 2025
  32. FROBERT O, Pedersen IB, Hjelholt AJ, Erikstrup C, et al
    The flu shot and cardiovascular Protection: Rethinking inflammation in ischemic heart disease.
    Atherosclerosis. 2025 Jun 13:120405. doi: 10.1016/j.atherosclerosis.2025.120405.
    >> Share

  33. MAGNONI M, Andreini D, Andreotti F, Latini R, et al
    Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaques.
    Atherosclerosis. 2025;407:120410.
    >> Share

  34. MYLONAS N, Nikolaou PE, Siokatas G, Kostopoulos IV, et al
    Empagliflozin restores cardiac metabolism and suppresses immune activation in acute myocardial infarction.
    Atherosclerosis. 2025;407:120404.
    >> Share

  35. WU JY, Chang HY, Kao CL, Hung KC, et al
    Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study.
    Atherosclerosis. 2025;407:120390.
    >> Share

  36. FUJIMOTO D, Kinoshita D, Suzuki K, Niida T, et al
    Coronary spotty calcification, compared with macro calcification, is associated with a higher level of vascular inflammation and plaque vulnerability in patients with stable angina.
    Atherosclerosis. 2025;405:119237.
    >> Share

    May 2025
  37. ELIAS-LOPEZ D, Kobylecki CJ, Vedel-Krogh S, Doi T, et al
    Association of low-grade inflammation and elevated remnant cholesterol with risk of ASCVD and mortality in impaired renal function.
    Atherosclerosis. 2025;406:119241.
    >> Share

  38. SUZUKI T, Haberlen S, Peterson TE, Palella F, et al
    Coronary artery calcium and all-cause mortality in the Multicenter AIDS Cohort Study.
    Atherosclerosis. 2025;404:119181.
    >> Share

  39. CONTE E, Lee SE, Chang HJ, Hadamitzky M, et al
    Sex related coronary plaque progression patterns among patients with family history as the sole cardiovascular risk factor: A PARADIGM sub-study.
    Atherosclerosis. 2025;404:119184.
    >> Share

    April 2025
  40. SANTOS RD, Ray KK, De Bacquer D, Jennings C, et al
    Frequency of residual combined dyslipidemia and hypertriglyceridemia in patients with coronary heart disease in 13 countries across 6 WHO Regions: Results from INTERASPIRE.
    Atherosclerosis. 2025;405:119215.
    >> Share

  41. TADA H, Nohara A, Usui S, Sakata K, et al
    Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia.
    Atherosclerosis. 2025;404:119185.
    >> Share

  42. FAROOQ S, Generoso G, Bensenor IM, Santos RD, et al
    Low-density lipoprotein-cholesterol subfractions as predictors for coronary artery calcium incidence and progression - The Brazilian longitudinal study of Adult Health (ELSA - Brasil).
    Atherosclerosis. 2025;403:119171.
    >> Share

  43. PIVORIUNAS J, Engebretsen I, Vethe NT, Kristiansen O, et al
    Statin adherence in coronary outpatients: The relationship between a novel blood test and pharmacy registry data.
    Atherosclerosis. 2025;403:119138.
    >> Share

  44. YUAN X, Zhang L, Li X, Chen K, et al
    Differential lipid impact on mortality in patients undergoing CABG versus PCI.
    Atherosclerosis. 2025;403:119141.
    >> Share

  45. FUJINO M, Di Giovanni G, Butters Bhsc J, Kataoka Y, et al
    Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS.
    Atherosclerosis. 2025;403:119145.
    >> Share

  46. ZHANG P, Wang W, Xu Q, Cui J, et al
    Genetic association of circulating lipids and lipid-lowering drug targets with vascular calcification.
    Atherosclerosis. 2025;403:119136.
    >> Share

    March 2025
  47. RIKHI R, Haidar A, Bhatia HS, Beam K, et al
    Association of lipoprotein(a) and diabetes in primary prevention of coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2025;404:119179.
    >> Share

  48. SADLER M, Cannata A, Mackie S, Mondi Anandhakrishna R, et al
    Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction.
    Atherosclerosis. 2025;403:119169.
    >> Share

  49. MOK Y, Ballew SH, Schrack JA, Howard CM, et al
    Mid-life physical activity and calcification of coronary arteries, aorta, and cardiac valves in late life: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2025;402:119115.
    >> Share

  50. YABUMOTO N, Fujino M, Sugane H, Hosoda H, et al
    Clinical implications of calcification severity adjacent to calcified nodule: Its association with first and recurrent risks of target lesion revascularization after percutaneous coronary intervention.
    Atherosclerosis. 2025;402:119116.
    >> Share

  51. ZHENG N, Liu Z, Ding Y, Wang X, et al
    Incremental prognostic value of pericoronary adipose tissue attenuation beyond conventional features in patients with nonobstructive coronary artery disease.
    Atherosclerosis. 2025;402:119075.
    >> Share

    February 2025
  52. ZHANG Y, Wu J, Wang N, Zhu J, et al
    Global burden and national health inequity of ischemic heart disease attributed to kidney dysfunction from 1990 to 2021: Findings from the global burden of disease study 2021.
    Atherosclerosis. 2025 Feb 26:119140. doi: 10.1016/j.atherosclerosis.2025.119140.
    >> Share

  53. KRUGER A, Willems van Dijk K, van Heemst D, Noordam R, et al
    Long-term body mass index trajectories and the risk of type 2 diabetes mellitus and atherosclerotic cardiovascular disease using healthcare data from UK Biobank participants.
    Atherosclerosis. 2025;403:119135.
    >> Share

  54. CHIGNON A, Lettre G
    Using omics data and genome editing methods to decipher GWAS loci associated with coronary artery disease.
    Atherosclerosis. 2025;401:118621.
    >> Share

  55. TUFARO V, Torii R, Aben JP, Parasa R, et al
    Can fast wall shear stress computation predict adverse cardiac events in patients with intermediate non-flow limiting stenoses?
    Atherosclerosis. 2025;401:119099.
    >> Share

  56. YI B, He L, Zhang D, Zeng M, et al
    Non-culprit plaque healing on serial OCT imaging and future outcome in patients with acute coronary syndromes.
    Atherosclerosis. 2025;401:119092.
    >> Share

  57. RAZIPOUR A, Grodecki K, Manral N, Geers J, et al
    AI-derived automated quantification of cardiac chambers and myocardium from non-contrast CT: Prediction of major adverse cardiovascular events in asymptomatic subjects.
    Atherosclerosis. 2025;401:119098.
    >> Share

  58. GIBSON K, Forrest IS, Petrazzini BO, Duffy A, et al
    Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK Biobank.
    Atherosclerosis. 2025;401:119103.
    >> Share

  59. MANIKPURAGE HD, Ricard J, Houessou U, Bourgault J, et al
    Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence.
    Atherosclerosis. 2025;401:119083.
    >> Share

  60. DREXEL H, Mader A, Larcher B, Festa A, et al
    Remnant cholesterol and long-term incidence of death in coronary artery disease patients.
    Atherosclerosis. 2025;401:119048.
    >> Share

    January 2025
  61. ARAUNA D, Chandia E, Nova-Lamperti E, Radojkovic C, et al
    Platelet Content from Acute Myocardial Infarction Patients: Elevated Levels of IL-6 and IL-8 and their impact on Endothelial Nitric Oxide Production.
    Atherosclerosis. 2025;403:119119.
    >> Share

    December 2024
  62. WANDELL P, Li X, Carlsson AC, Sundquist J, et al
    Myocardial infarction in second-generation immigrants compared to native-born Swedes in the total population of Sweden.
    Atherosclerosis. 2024 Dec 26:119102. doi: 10.1016/j.atherosclerosis.2024.119102.
    >> Share

  63. KYHL LK, Nordestgaard BG, Tybjaerg-Hansen A, Smith GD, et al
    VLDL triglycerides and cholesterol in non-alcoholic fatty liver disease and myocardial infarction.
    Atherosclerosis. 2024;401:119094.
    >> Share

  64. JUHASZ V, Charlier FT, Zhao TX, Tsiantoulas D, et al
    Targeting the adaptive immune continuum in atherosclerosis and post-MI injury.
    Atherosclerosis. 2024;399:118616.
    >> Share

  65. KATAOKA T, Morishita T, Uzui H, Sato Y, et al
    Very short-term effects of a single dose of a proprotein convertase subtilisin/kexin 9 inhibitor before percutaneous coronary intervention: A single-arm study.
    Atherosclerosis. 2024;399:118581.
    >> Share

    November 2024
  66. MENG Q, Zhao L, Zhao N, An Y, et al
    Progression of coronary artery calcium density and major adverse cardiovascular events.
    Atherosclerosis. 2024;398:118593.
    >> Share

  67. KLUNER LV, Chan K, Antoniades C
    Using artificial intelligence to study atherosclerosis from computed tomography imaging: A state-of-the-art review of the current literature.
    Atherosclerosis. 2024;398:117580.
    >> Share

  68. LEIVA O, Zhou S, How J, Lee M, et al
    Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasms.
    Atherosclerosis. 2024;401:119046.
    >> Share

    October 2024
  69. SIMONY SB, Langsted A, Mortensen MB, Nordestgaard BG, et al
    Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study.
    Atherosclerosis. 2024;399:118625.
    >> Share

  70. HAGAN K, Mszar R, Cainzos-Achirica M, Blaha MJ, et al
    Low-density lipoprotein-cholesterol and subclinical coronary atherosclerosis in a middle-aged asymptomatic U.S. population: The Miami Heart Study at Baptist Health South Florida.
    Atherosclerosis. 2024;397:118551.
    >> Share

  71. KILBO EDLUND K, Andersson EM, Asker C, Barregard L, et al
    Long-term ambient air pollution and coronary atherosclerosis: Results from the Swedish SCAPIS study.
    Atherosclerosis. 2024;397:117576.
    >> Share

  72. GUGLIELMO M, Penso M, Carerj ML, Giacari CM, et al
    DEep LearnIng-based QuaNtification of epicardial adipose tissue predicts MACE in patients undergoing stress CMR.
    Atherosclerosis. 2024;397:117549.
    >> Share

    September 2024
  73. ALDUJELI A, Tsai TY, Haq A, Tatarunas V, et al
    The association between trimethylamine N-oxide levels and coronary microvascular dysfunction and prognosis in patients with ST-elevation myocardial infarction.
    Atherosclerosis. 2024;398:118597.
    >> Share

  74. VALLEJO-VAZ AJ, Dharmayat KI, Nzeakor N, Carrasco CP, et al
    Recurrent cardiovascular and limb events in 294,428 patients with coronary or peripheral artery disease or ischemic stroke on antiplatelet monotherapy: The RESRISK cohort study.
    Atherosclerosis. 2024;398:118589.
    >> Share

  75. QIU J, Fu Y, Tian T, Mao Y, et al
    Suppression of FOXC1 induces pyroptosis of the coronary artery through activation of JAK2.
    Atherosclerosis. 2024;396:118543.
    >> Share

    August 2024
  76. EYRICH TM, Dalila N, Christoffersen M, Tybjaerg-Hansen A, et al
    Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population.
    Atherosclerosis. 2024;397:118574.
    >> Share

  77. VOLLEBERG RHJA, Mol JQ, Belkacemi A, Hermanides RS, et al
    Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction.
    Atherosclerosis. 2024;397:118568.
    >> Share

  78. VAISAR T, Babenko I, Horvath KV, Niisuke K, et al
    Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease.
    Atherosclerosis. 2024;397:118565.
    >> Share

  79. CHEN JX, Lu Q, Geng T, Wang Y, et al
    Differences in HDL-related coronary heart disease risk between individuals with and without diabetes.
    Atherosclerosis. 2024;397:118553.
    >> Share

  80. TRAMUJAS L, Nogueira A, Felix N, de Barros E Silva PGM, et al
    Association of colchicine use with cardiovascular and limb events in peripheral artery disease: Insights from a retrospective cohort study.
    Atherosclerosis. 2024 Aug 9:118563. doi: 10.1016/j.atherosclerosis.2024.118563.
    >> Share

  81. QI X, Zhang Y, Wang Y, Sun J, et al
    Prognostic value of serum immunoglobulin M levels in patients with acute coronary syndrome.
    Atherosclerosis. 2024;395:117552.
    >> Share

  82. WENTZEL JJ, Bos D, White SJ, van der Heiden K, et al
    Sex-related differences in coronary and carotid vessel geometry, plaque composition and shear stress obtained from imaging.
    Atherosclerosis. 2024;395:117616.
    >> Share

  83. PATEL NH, Dave EK, Fatade YA, De Cecco CN, et al
    Epicardial adipose tissue attenuation on computed tomography in women with coronary microvascular dysfunction: A pilot, hypothesis generating study.
    Atherosclerosis. 2024;395:118520.
    >> Share

  84. MIRANDA MARAVI JS, Leszczynski EC, Schwartz CS, Dev PK, et al
    Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study.
    Atherosclerosis. 2024;395:117587.
    >> Share

  85. ZHANG J, Zhong Q, Lin Y, Zhang Y, et al
    Longitudinal albuminuria patterns predict coronary artery calcification progression: Findings from the Coronary Artery Risk Development in Young Adults study.
    Atherosclerosis. 2024;395:117574.
    >> Share

  86. FERRARO B
    The SR-B1DeltaCT/LDLR KO mouse: A new tool to shed light on coronary artery disease.
    Atherosclerosis. 2024;395:117564.
    >> Share

  87. HOSHINO M, Jukema RA, Pijls N, Hoek R, et al
    Microvascular resistance reserve before and after PCI: A serial FFR and [(15)O] H(2)O PET study.
    Atherosclerosis. 2024;395:117555.
    >> Share

  88. PARK CH, Kim HW, Park JT, Chang TI, et al
    Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study.
    Atherosclerosis. 2024;395:117563.
    >> Share

  89. MULLIS DM, Padilla-Lopez A, Wang H, Zhu Y, et al
    Stromal cell-derived factor-1 alpha improves cardiac function in a novel diet-induced coronary atherosclerosis model, the SR-B1DeltaCT/LDLR KO mouse.
    Atherosclerosis. 2024;395:117518.
    >> Share

  90. OLIVEIRA-SANTOS M, Borges-Rosa J, Silva R, Paixao L, et al
    Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT.
    Atherosclerosis. 2024;395:117481.
    >> Share

    July 2024
  91. HUANG H, Liu J, Li Q, Qiao L, et al
    Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation.
    Atherosclerosis. 2024;394:117306.
    >> Share

    June 2024
  92. BEN-SHABAT N, Krasun A, Fisher L, Patt YS, et al
    Anti-Ro and anti-La seropositivity is associated with increased rates of ischemic heart disease in adults: Results from a large population-based study.
    Atherosclerosis. 2024;396:117626.
    >> Share

  93. IBRAHIM S, Hartgers ML, Reeskamp LF, Zuurbier L, et al
    LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia.
    Atherosclerosis. 2024 Jun 10:117610. doi: 10.1016/j.atherosclerosis.2024.117610.
    >> Share

  94. GAGNON E, Bourgault J, Gobeil E, Theriault S, et al
    Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
    Atherosclerosis. 2024;393:117558.
    >> Share

  95. GOUDA P, Islam S, Dover DC, Kaul P, et al
    Outcomes of management strategies in patients with prior coronary artery bypass grafting presenting with an acute coronary syndrome.
    Atherosclerosis. 2024;393:117477.
    >> Share

  96. MASROURI S, Tamehri Zadeh SS, Shapiro MD, Khalili D, et al
    Impact of optimal cholesterol levels on subclinical atherosclerosis in the absence of risk factors in young adults.
    Atherosclerosis. 2024;393:117520.
    >> Share

  97. WELSH RC, Gouda P, Dover D, Bainey KR, et al
    Applicability and impact of the COMPASS trial in a Canadian population of patients with atherosclerotic disease.
    Atherosclerosis. 2024;393:117486.
    >> Share

    May 2024
  98. PINXTERHUIS TH, Ploumen EH, van Vliet D, Gert van Houwelingen K, et al
    Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.
    Atherosclerosis. 2024;392:117488.
    >> Share

  99. JAIN V, Rifai MA, Kanaya AM, Shah NS, et al
    Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies.
    Atherosclerosis. 2024;392:117522.
    >> Share

  100. SUGANE H, Asaumi Y, Ogata S, Kimura M, et al
    Evaluation of fractional flow reserve and atherosclerotic plaque characteristics on coronary non-contrast T1-weighted magnetic resonance imaging.
    Atherosclerosis. 2024;392:117530.
    >> Share

  101. BERLOT AA, Fu X, Shea MK, Tracy R, et al
    Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2024;392:117505.
    >> Share

  102. LARSSON J, Auscher S, Pararajasingam G, Heinsen LJ, et al
    Reply to: "Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition".
    Atherosclerosis. 2024;392:117524.
    >> Share

  103. RAZAVI AC, Raggi P, Whelton SP
    Coronary artery calcium: The canary in the coal mine.
    Atherosclerosis. 2024;392:117499.
    >> Share

  104. BUGIARDINI R, Gulati M
    Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity.
    Atherosclerosis. 2024;392:117500.
    >> Share

  105. BERISHA-MUHARREMI V, Majnaric-Trtica L, Mujaj B
    Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition.
    Atherosclerosis. 2024;392:117484.
    >> Share

    April 2024
  106. ENGEBRETSEN I, Bugge C, Stovring H, Husebye E, et al
    Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event.
    Atherosclerosis. 2024;393:117550.
    >> Share

  107. XIAO J, Wei H, Gao Z, Chen L, et al
    Differential age-specific associations of LDL cholesterol and body mass index with coronary heart disease.
    Atherosclerosis. 2024;393:117542.
    >> Share

  108. GAGNON E, Arsenault BJ
    Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention.
    Atherosclerosis. 2024;391:117501.
    >> Share

  109. HAN Y, Ren L, Fei X, Wang J, et al
    Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH).
    Atherosclerosis. 2024;391:117471.
    >> Share

  110. RINALDI R, Colucci M, Torre I, Ausiello D, et al
    Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: The ABCD score.
    Atherosclerosis. 2024;391:117503.
    >> Share

    March 2024
  111. MELNES T, Bogsrud MP, Christensen JJ, Rundblad A, et al
    Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease.
    Atherosclerosis. 2024;392:117507.
    >> Share

  112. ESCATE R, Padro T, Perez de Isla L, Fuentes F, et al
    Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients.
    Atherosclerosis. 2024;392:117502.
    >> Share

  113. REXHAJ E, Bar S, Soria R, Ueki Y, et al
    Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
    Atherosclerosis. 2024;392:117504.
    >> Share

  114. HAKAMAA E, Goebeler S, Martiskainen M, Louhelainen AM, et al
    Sex differences in coronary atherosclerosis during the pre- and postmenopausal period: The Tampere Sudden Death Study.
    Atherosclerosis. 2024;390:117459.
    >> Share

  115. GRINBERG T, Eisen A, Talmor-Barkan Y, Kornowski R, et al
    Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort.
    Atherosclerosis. 2024;390:117469.
    >> Share

  116. SCHLEGEL A
    Diagnostic challenge of an APOB variant of uncertain significance resolved by transheterozygosity with a pathological LDLR variant and clinical response to therapy.
    Atherosclerosis. 2024;390:117460.
    >> Share

  117. CHEDID G, Malik A, Daher R, Welty FK, et al
    Reply to: "Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease"".
    Atherosclerosis. 2024;390:117452.
    >> Share

  118. KHAN SU, Al-Mallah MH
    Air pollution and acute coronary syndrome: The air we breathe.
    Atherosclerosis. 2024;390:117453.
    >> Share

  119. GU SZ, Ahmed ME, Huang Y, Hakim D, et al
    Comprehensive biomechanical and anatomical atherosclerotic plaque metrics predict major adverse cardiovascular events: A new tool for clinical decision making.
    Atherosclerosis. 2024;390:117449.
    >> Share

  120. CENKO E, Manfrini O, Bugiardini R
    Net adverse clinical events with P2Y(12) inhibitor therapy in older patients after percutaneous coronary interventions.
    Atherosclerosis. 2024;390:117434.
    >> Share

  121. ASMARIAN N, Raeisi Shahraki H
    Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease".
    Atherosclerosis. 2024;390:117426.
    >> Share

  122. RINALDI R, Russo M, Bonanni A, Camilli M, et al
    Short-term air pollution exposure and mechanisms of plaque instability in acute coronary syndromes: An optical coherence tomography study.
    Atherosclerosis. 2024;390:117393.
    >> Share

    February 2024
  123. OBISESAN OH, Boakye E, Wang FM, Dardari Z, et al
    Coronary artery calcium as a marker of healthy and unhealthy aging in adults aged 75 and older: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2024 Feb 13:117475. doi: 10.1016/j.atherosclerosis.2024.117475.
    >> Share

    December 2023
  124. FISHBEIN I, Inamdar VV, Alferiev IS, Bratinov G, et al
    Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the mitigating effect of stent surface modification with a CD47-derived peptide.
    Atherosclerosis. 2023;390:117432.
    >> Share

  125. ZHANG D, Li P, Qiu M, Liang Z, et al
    Net clinical benefit of clopidogrel versus ticagrelor in elderly patients carrying CYP2C19 loss-of-function variants with acute coronary syndrome after percutaneous coronary intervention.
    Atherosclerosis. 2023 Dec 13:117395. doi: 10.1016/j.atherosclerosis.2023.117395.
    >> Share

    September 2023
  126. JONAS M, Genereux P, Maehara A, Ben-Yehuda O, et al
    Control of diabetes mellitus and the risk of neointimal hyperplasia after percutaneous coronary intervention: Post-hoc analysis from the BLADE-PCI trial.
    Atherosclerosis. 2023 Sep 3:117264. doi: 10.1016/j.atherosclerosis.2023.117264.
    >> Share

    August 2023
  127. TIAN P, Liu Y, Wang J, Xing L, et al
    Correlation of neck circumference, coronary calcification severity and cardiovascular events in Chinese elderly patients with acute coronary syndromes.
    Atherosclerosis. 2023 Aug 18:117242. doi: 10.1016/j.atherosclerosis.2023.117242.
    >> Share

    July 2023
  128. BARFOROSHI S, Manubolu VS, Wang R, McClelland RL, et al
    Incremental value of ABI and CAC beyond traditional risk markers in long-term prediction of cardiovascular disease incidence in participants with diabetes and impaired fasting glucose: Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2023 Jul 6:117186. doi: 10.1016/j.atherosclerosis.2023.117186.
    >> Share

    June 2023
  129. NIELSEN S, Nyvad J, Christensen KL, Poulsen PL, et al
    Obstructive sleep apnea, coronary calcification and arterial stiffness in patients with diabetic kidney disease.
    Atherosclerosis. 2023 Jun 29:117170. doi: 10.1016/j.atherosclerosis.2023.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016